Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
9.75
+0.15 (1.56%)
At close: Sep 26, 2025, 4:00 PM EDT
9.63
-0.12 (-1.23%)
After-hours: Sep 26, 2025, 4:45 PM EDT
Amneal Pharmaceuticals Employees
Amneal Pharmaceuticals had 8,300 employees as of December 31, 2024. The number of employees increased by 450 or 5.73% compared to the previous year.
Employees
8,300
Change (1Y)
450
Growth (1Y)
5.73%
Revenue / Employee
$343,725
Profits / Employee
$407
Market Cap
3.06B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AMRX News
- 1 day ago - Amneal Announces BLA Submission of Biosimilar Candidate to XOLAIR® (omalizumab) - GlobeNewsWire
- 4 days ago - Amneal Receives U.S. FDA Approval for Bimatoprost Ophthalmic Solution, 0.01% - GlobeNewsWire
- 16 days ago - Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution - GlobeNewsWire
- 16 days ago - Amneal Pharmaceuticals: A Large, Diversified Clinical Portfolio That Keeps Growing - Seeking Alpha
- 23 days ago - Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension - GlobeNewsWire
- 7 weeks ago - Amneal Pharmaceuticals, Inc. (AMRX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Knight Therapeutics Announces Regulatory Submission of CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Mexico - GlobeNewsWire
- 7 weeks ago - Amneal Reports Second Quarter 2025 Financial Results - GlobeNewsWire